---
title: "Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program | B Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281140934.md"
description: "Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program | B Stock News"
datetime: "2026-03-30T23:15:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281140934.md)
  - [en](https://longbridge.com/en/news/281140934.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281140934.md)
---

# Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program | B Stock News

Cereno Scientific Reports Favorable Safety and Tolerability after 12 Months of CS1 Treatment in PAH from the Expanded Access Program | B Stock News

### Related Stocks

- [CERO.US](https://longbridge.com/en/quote/CERO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md)
- [Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US](https://longbridge.com/en/news/293415324.md)
- [Has the bull market shifted to biotech stocks?](https://longbridge.com/en/news/293077044.md)
- [Cero Therapeutics Secures $2.09M 10% Convertible Note With SRX Global, Maturing May 2027](https://longbridge.com/en/news/293073319.md)